OL
Optimeos Life Sciences, Inc.
SEC filingBiotechnology · Princeton, NJ
Amount raised$1Msold at filing
Total offering$2M$1M still open
Investors in the raise1count reported to the SEC
FiledJun 3, 2026first sale May 22, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Jason K SmithDirector
Shahram HejaziExecutive Officer, Director
Robert K Prud'hommeDirector
Benjamin K DoranzDirector
Executive officers, directors and promoters as listed on the Form D.